Background and aim: Clinical characteristics of resistant hypertensive patients in comparison to controlled patients have not been fully investigated in large cohorts. The aim of the study was to evaluate clinical differences, target organ damage and ambulatory blood pressure monitoring in resistant hypertensive patients and patients controlled on three or less drugs.
Methods: In December 2010, from the Spanish Ambulatory Blood Pressure Monitoring Registry, we identified 14 461 patients fulfilling criteria of resistant hypertension and 13 436 hypertensive patients controlled on three or less drugs. Clinical characteristics were compared between these two groups.
Results: Compared to controlled patients, those having resistant hypertension were older, more obese and had longer hypertension duration. They also had more frequently diabetes, dyslipidemia, reduced renal function, microalbuminuria, left-ventricular hypertrophy and previous history of cardiovascular events. In multivariate analyses, hypertension duration, obesity, abdominal obesity, left-ventricular hypertrophy, reduced estimated glomerular filtration rate, and microalbuminuria were independently associated with resistant hypertension. Resistant hypertensive patients had higher ambulatory blood pressures, but differences between office and ambulatory blood pressure (white-coat effect) were also more pronounced in this group, revealing a proportion of 40% of patients with normal 24-h blood pressure. On the contrary, values of 24-h blood pressure above 130 and/or 80 mmHg (masked hypertension) were present in 31% of apparently controlled patients.
Conclusion: Resistant hypertension is associated with obesity, longer hypertension duration and kidney and cardiac damage. Ambulatory blood pressure monitoring reveals that white-coat hypertension is common among resistant hypertensive patients, as well as is masked hypertension among apparently controlled patients.
aDepartment of Internal Medicine, Hospital Mutua Terrassa, University of Barcelona
bDepartment of Preventive Medicine and Public Health, Autonomous University, Madrid
cHypertension Unit, Hospital del Mar, Barcelona
dDepartment of Nephrology, Hospital Universitario Central de Asturias, Oviedo
eHypertension Unit, Hospital 12 de Octubre, Madrid
fDepartment of Internal Medicine, Hospital General de L’Hospitalet, Barcelona, Spain
Correspondence to Alejandro de la Sierra, Department of Internal Medicine, Hospital Mutua Terrassa, University of Barcelona, Plaza Dr Robert, 5, 08221-Terrassa, Spain.Tel: +34 937365000, ext 1295; fax: +34 937365037; e-mail: email@example.com;firstname.lastname@example.org
Abbreviations: ABPM, ambulatory blood pressure monitoring; ASCOT, Anglo Scandinavian Cardiac Outcome Trial; BP, blood pressure; CI, confidence interval; GFR, glomerular filtration rate; LDL, low-density lipoprotein; LVH, left-ventricular hypertrophy; MDRD, Modification of Diet in Renal Disease; MOR, multivariate odds ratio; NHANES, National Health and Examination Surveys; SPSS, Statistical Package for Social Sciences; UAE, urinary albumin excretion
Received 3 October, 2011
Revised 2 February, 2012
Accepted 7 March, 2012
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.jhypertension.com).